-Search query
-Search result
Showing 1 - 50 of 65 items for (author: tate & c)

EMDB-61302:
Cryo-EM structure of the class I amyloid-beta 42 fibril containing a D-Asp at position 23
Method: helical / : Hsiao LC, Lee CH, Hsu MF, Hsu ST

EMDB-61303:
Cryo-EM structure of the class II amyloid-beta 42 fibril containing a D-Asp at position 23
Method: helical / : Hsiao LC, Lee CH, Hsu MF, Hsu ST

EMDB-61304:
Cryo-EM structure of the type I amyloid-beta 42 fibril containing a D-Asp at positions 7 and 23
Method: helical / : Hsiao LC, Lee CH, Hsu MF, Hsu ST

EMDB-61305:
Cryo-EM structure of the type II amyloid-beta 42 fibril containing a D-Asp at positions 7 and 23
Method: helical / : Hsiao LC, Lee CH, Hsu MF, Hsu ST

PDB-9jaz:
Cryo-EM structure of the class I amyloid-beta 42 fibril containing a D-Asp at position 23
Method: helical / : Hsiao LC, Lee CH, Hsu MF, Hsu ST

PDB-9jb0:
Cryo-EM structure of the class II amyloid-beta 42 fibril containing a D-Asp at position 23
Method: helical / : Hsiao LC, Lee CH, Hsu MF, Hsu ST

PDB-9jb1:
Cryo-EM structure of the type I amyloid-beta 42 fibril containing a D-Asp at positions 7 and 23
Method: helical / : Hsiao LC, Lee CH, Hsu MF, Hsu ST

PDB-9jb2:
Cryo-EM structure of the type II amyloid-beta 42 fibril containing a D-Asp at positions 7 and 23
Method: helical / : Hsiao LC, Lee CH, Hsu MF, Hsu ST

EMDB-34741:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-34742:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 focused on RBD and NIV-11 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgl:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgm:
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-17756:
Structure of the murine trace amine-associated receptor TAAR7f bound to N,N-dimethylcyclohexylamine (DMCH) in complex with mini-Gs trimeric G protein
Method: single particle / : Gusach A, Lee Y, Edwards PC, Huang F, Weyand SN, Tate CG

PDB-8pm2:
Structure of the murine trace amine-associated receptor TAAR7f bound to N,N-dimethylcyclohexylamine (DMCH) in complex with mini-Gs trimeric G protein
Method: single particle / : Gusach A, Lee Y, Edwards PC, Huang F, Weyand SN, Tate CG

EMDB-33820:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 focused on RBD and NIV-8 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33821:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33822:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33823:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 focused on RBD and NIV-10 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33824:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33825:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33826:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33827:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 focused on RBD and NIV-13 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33828:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33829:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33830:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh6:
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh7:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-15779:
CryoEM structure of C5b8-CD59
Method: single particle / : Bubeck D, Couves EC, Gardner S

EMDB-15780:
2C9, C5b9-CD59 structure
Method: single particle / : Couves EC, Gardner S, Bubeck D

EMDB-15781:
2C9, C5b9-CD59 cryoEM structure
Method: single particle / : Couves EC, Gardner S, Bubeck D

EMDB-15782:
2C9, C5b9-CD59 cryoEM structure; focus refinement map
Method: single particle / : Couves EC, Gardner S, Bubeck D

EMDB-15783:
3C9, C5b9-CD59 cryoEM structure; focus refinement map
Method: single particle / : Couves EC, Gardner S, Bubeck D

EMDB-15800:
CryoEM reconstruction of C5b8-CD59, density subtracted
Method: single particle / : Bubeck D, Couves EC, Gardner S

EMDB-27243:
Cryo-EM map of MORF-WHs in complex with 197bp nucleosome aided by scFv
Method: single particle / : Zhou BR

EMDB-13764:
Structure of Hedgehog acyltransferase (HHAT) in complex with megabody 177 bound to non-hydrolysable palmitoyl-CoA (Composite Map)
Method: single particle / : Coupland C, Carrique L, Siebold C

PDB-7q1u:
Structure of Hedgehog acyltransferase (HHAT) in complex with megabody 177 bound to non-hydrolysable palmitoyl-CoA (Composite Map)
Method: single particle / : Coupland C, Carrique L, Siebold C

EMDB-14578:
Structure of Hedgehog acyltransferase (HHAT) in complex with megabody 177 bound to non-hydrolysable palmitoyl-CoA (Consensus Map)
Method: single particle / : Coupland C, Carrique L, Siebold C

EMDB-13880:
Structure of the GPCR dimer Ste2 bound to an antagonist
Method: single particle / : Velazhahan V, Tate CG

EMDB-13882:
Structure of the ligand-free GPCR dimer Ste2
Method: single particle / : Velazhahan V, Tate CG

EMDB-13886:
Structure of the GPCR dimer Ste2 in the inactive-like state bound to agonist
Method: single particle / : Velazhahan V, Tate CG

EMDB-13887:
Structure of the GPCR dimer Ste2 in the active-like state bound to agonist
Method: single particle / : Velazhahan V, Tate CG

PDB-7qa8:
Structure of the GPCR dimer Ste2 bound to an antagonist
Method: single particle / : Velazhahan V, Tate CG

PDB-7qb9:
Structure of the ligand-free GPCR dimer Ste2
Method: single particle / : Velazhahan V, Tate CG

PDB-7qbc:
Structure of the GPCR dimer Ste2 in the inactive-like state bound to agonist
Method: single particle / : Velazhahan V, Tate CG

PDB-7qbi:
Structure of the GPCR dimer Ste2 in the active-like state bound to agonist
Method: single particle / : Velazhahan V, Tate CG

EMDB-13860:
Structure of Hedgehog acyltransferase (HHAT) in complex with megabody 177 bound to IMP-1575
Method: single particle / : Coupland C, Carrique L

PDB-7q6z:
Structure of Hedgehog acyltransferase (HHAT) in complex with megabody 177 bound to IMP-1575
Method: single particle / : Coupland C, Carrique L, Siebold C
Pages: